Search results
27 mar 2024 · This economic evaluation study estimated the cost of production for insulins, SGLT2Is, and GLP1As, and, based on this, a sustainable cost-based price (CBP), and compared CBPs with the current lowest reported prices in 12 countries, collected in January 2023 from public databases.
11 paź 2024 · Find the most popular and affordable Diabetes Type 2 medication. Save with or without insurance on brand and generic alternatives used to treat Diabetes Type 2.
14 paź 2021 · Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
16 cze 2023 · List prices were estimated as mean reimbursement rates in Medicare Part D per 100 insulin units. Net prices were estimated as the difference between list prices and commercial discounts and represent the prices faced by Part D and private plans after rebates.
11 cze 2020 · We classified the interventions based on their strength of evidence (strong, supportive, or uncertain) and levels of CE: cost-saving (more health benefit at a lower cost), very cost-effective (≤$25,000 per life year gained [LYG] or quality-adjusted life year [QALY]), cost-effective ($25,001–$50,000 per LYG or QALY), marginally cost ...
17 cze 2020 · Direct costs. The direct costs of living with diabetes includes: medical supplies. doctor’s visits. hospital care. prescription medications. Of the $237 billion spent on direct costs in 2017,...
11 wrz 2020 · In this issue of Diabetes Care, Zhou et al. (13) estimate the economic cost of glucose-lowering drugs at $57.6 billion per year in the U.S. in 2015–2017 (∼15–20% of the estimated annual cost for all prescription drugs in the U.S.).
